Back to search results

Moms Managing ADHD Study for Pregnant Individuals

This study is testing a new behavioral program called MomMA (Moms Managing ADHD) for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). The program uses a type of talk therapy (CBT-based behavioral intervention) to help you manage ADHD symptoms during and after pregnancy. Therapists will provide these sessions in your OB care setting. To join, you must be a woman between 18 and 55 years old, 20-32 weeks pregnant, speak English, and plan to deliver at UPMC Magee Women's Hospital. The study aims to see if the MomMA program is acceptable, appropriate, and practical for participants. The current recruitment status is unclear, and the study plans to enroll 10 participants.

Study design
This is an interventional study, meaning you will receive a specific treatment. It is an open clinical trial, planning to include 10 pregnant individuals.
What's involved
You will receive sessions of the MomMA Intervention from therapists embedded in OB care settings. The study will measure how acceptable, appropriate, and feasible the intervention is after delivery at 4-month postpartum.
Compensation
Not stated in the trial record.
Follow-up
Your progress will be measured after the intervention at 4-month postpartum.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06540547

Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study

Recruiting
NAAges 18–55InterventionalTreatment
University of Pittsburgh
~10 participants
Updated 2026-01-08 on ClinicalTrials.gov
What's tested:MomMA Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Intervention Acceptability
Measured over Post Intervention at 4-month postpartum
+2 more outcomes measured

Conditions

ADHD
Parenting

Explore related trials

Attention Deficit Hyperactivity Disorder

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Heather M Joseph, DO · PRINCIPAL_INVESTIGATOR · University of Pittsburgh

Who to contact

Heather M Joseph, DO
[email protected]
4122465339
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

(1) meet full DSM-5 criteria for ADHD
(2) are between 20- and 32-weeks of gestation
(3) speak English
(4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women's Hospital (MWH)

Exclusion

(1) active substance use disorder
(2) intellectual disability
(3) other severe mental illness, including bipolar disorder, psychosis, and major depressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient)
(4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have a severe congenital condition.

What this trial measures

  • Intervention AcceptabilityPost Intervention at 4-month postpartum

    Therapist and participant report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from rated from 1 (completely disagree) to 5 (completely agree), with scores greater than or equal to 16 indicating good acceptability.

  • Intervention AppropriatenessPost Intervention at 4-month postpartum

    Therapist and participant report of intervention appropriateness will be assessed using the 4-item Intervention Appropriateness Measure (IAM), rated from 1 (completely disagree) to 5 (completely agree), with scores greater than or equal to 16 indicating good appropriateness.

  • Intervention FeasibilityPost Intervention at 4-month postpartum

    Therapist and participant report of intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM), rated from 1 (completely disagree) to 5 (completely agree), with scores greater than or equal to 16 indicating good feasibility.